The ethics of innovation for Alzheimer's disease: the risk of overstating evidence for metabolic enhancement protocols.
Saved in:
| Title: | The ethics of innovation for Alzheimer's disease: the risk of overstating evidence for metabolic enhancement protocols. |
|---|---|
| Authors: | Daly T; Sorbonne University, Paris, France. timothy.daly@paris-sorbonne.fr., Mastroleo I; National Scientific and Technical Research Council, Buenos Aires, Argentina., Gorski D; Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA., Epelbaum S; Institut du Cerveau et de la Moelle épinière (Brain and Spine Institute), Paris, France. |
| Source: | Theoretical medicine and bioethics [Theor Med Bioeth] 2020 Dec; Vol. 41 (5-6), pp. 223-237. Date of Electronic Publication: 2021 Jan 18. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer Country of Publication: Netherlands NLM ID: 9805378 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0980 (Electronic) Linking ISSN: 13867415 NLM ISO Abbreviation: Theor Med Bioeth Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33459944 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The ethics of innovation for Alzheimer's disease: the risk of overstating evidence for metabolic enhancement protocols. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Daly+T%22">Daly T</searchLink>; Sorbonne University, Paris, France. timothy.daly@paris-sorbonne.fr.<br /><searchLink fieldCode="AU" term="%22Mastroleo+I%22">Mastroleo I</searchLink>; National Scientific and Technical Research Council, Buenos Aires, Argentina.<br /><searchLink fieldCode="AU" term="%22Gorski+D%22">Gorski D</searchLink>; Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA.<br /><searchLink fieldCode="AU" term="%22Epelbaum+S%22">Epelbaum S</searchLink>; Institut du Cerveau et de la Moelle épinière (Brain and Spine Institute), Paris, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229805378%22">Theoretical medicine and bioethics</searchLink> [Theor Med Bioeth] 2020 Dec; Vol. 41 (5-6), pp. 223-237. <i>Date of Electronic Publication: </i>2021 Jan 18. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>9805378 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-0980 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213867415%22">13867415 </searchLink><i>NLM ISO Abbreviation: </i>Theor Med Bioeth <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33459944 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s11017-020-09536-7 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 223 Titles: – TitleFull: The ethics of innovation for Alzheimer's disease: the risk of overstating evidence for metabolic enhancement protocols. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Daly T – PersonEntity: Name: NameFull: Mastroleo I – PersonEntity: Name: NameFull: Gorski D – PersonEntity: Name: NameFull: Epelbaum S IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2020 Dec Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1573-0980 Numbering: – Type: volume Value: 41 – Type: issue Value: 5-6 Titles: – TitleFull: Theoretical medicine and bioethics Type: main |
| ResultId | 1 |